Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date

MLA

Bylicki O, et al. “Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date.” OncoTargets and Therapy, June 2020, pp. 5691–706. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..616298a0c059021bdb0ed4966a766fdd&authtype=sso&custid=ns315887.

APA

Bylicki O, Paleiron N, Assié JB, & Chouaïd C. (2020). Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date. OncoTargets and Therapy, 5691–5706.

Chicago

Bylicki O, Paleiron N, Assié JB, and Chouaïd C. 2020. “Targeting the MET-Signaling Pathway in Non-Small–Cell Lung Cancer: Evidence to Date.” OncoTargets and Therapy, June, 5691–5706. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doajarticles..616298a0c059021bdb0ed4966a766fdd&authtype=sso&custid=ns315887.